Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function  

作　　者：Li-Jun Yao Xiao-Ding Zhu Liu-Min Zhou Li-Li Zhang Na-Na Liu Min Chen Jia-Ying Wang Shao-Jun Hu 

机构地区：[1]Department of Oncology,Suzhou Ninth People's Hospital,Suzhou 215200,Jiangsu Province,China [2]Department of Rehabilitation,Suzhou Xiangcheng District Rehabilitation Hospital,Suzhou 215132,Jiangsu Province,China

出　　处：《World Journal of Clinical Cases》2024年第18期3395-3402,共8页世界临床病例杂志

摘　　要：BACKGROUND Hepatectomy is the first choice for treating liver cancer.However,inflammatory factors,released in response to pain stimulation,may suppress perioperative immune function and affect the prognosis of patients undergoing hepatectomies.AIM To determine the short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function.METHODS Clinical data from patients with liver cancer admitted to Suzhou Ninth People’s Hospital from January 2020 to December 2023 were retrospectively analyzed.Thirty-five patients underwent laparoscopic hepatectomy for liver cancer(liver cancer resection group)and 35 patients underwent medical image-guided microwave ablation(liver cancer ablation group).The short-term efficacy,complications,liver function,and immune function indices before and after treatment were compared between the two groups.RESULTS One month after treatment,19 patients experienced complete remission(CR),8 patients experienced partial remission(PR),6 patients experienced stable disease(SD),and 2 patients experienced disease progression(PD)in the liver cancer resection group.In the liver cancer ablation group,21 patients experienced CR,9 patients experienced PR,3 patients experienced SD,and 2 patients experienced PD.No significant differences in efficacy and complications were detected between the liver cancer ablation and liver cancer resection groups(P>0.05).After treatment,total bilirubin(41.24±7.35 vs 49.18±8.64μmol/L,P<0.001),alanine aminotransferase(30.85±6.23 vs 42.32±7.56 U/L,P<0.001),CD4+(43.95±5.72 vs 35.27±5.56,P<0.001),CD8+(20.38±3.91 vs 22.75±4.62,P<0.001),and CD4+/CD8+(2.16±0.39 vs 1.55±0.32,P<0.001)were significantly different between the liver cancer ablation and liver cancer resection groups.CONCLUSION The short-term efficacy and safety of microwave ablation and laparoscopic surgery for the treatment of liver cancer are similar,but liver function recovers quickly after microwave ablation,and microwave ablation may enhance immune function.

关 键 词：Microwave ablation Liver cancer Short-term efficacy Liver function Immunologic function 

分 类 号：R735.7[医药卫生—肿瘤]